SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-022458
Filing Date
2023-06-16
Accepted
2023-06-16 16:08:41
Documents
2
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_168694610673749.html 4  
1 FORM 4 wf-form4_168694610673749.xml 4 5349
2 FISCHER POA ex24fischer.txt EX-24 3925
  Complete submission text file 0001628280-23-022458.txt   10860
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRIUS THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE, SUITE 101 SAN DIEGO CA 92121
Business Address
Fischer Seth H. Z. (Reporting) CIK: 0001573553 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 231021125